NCT06032780 Eccentric Resistance Training Among Individuals With Chronic Heart Failure
| NCT ID | NCT06032780 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Riphah International University |
| Condition | Heart Failure |
| Study Type | INTERVENTIONAL |
| Enrollment | 84 participants |
| Start Date | 2023-09-20 |
| Primary Completion | 2026-05 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 84 participants in total. It began in 2023-09-20 with a primary completion date of 2026-05.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
To determine the effects of eccentric resistive training on ventricle functions and aerobic capacity as compared to a resistance and aerobic training among Heart failure (HF)
Eligibility Criteria
Inclusion Criteria: * Diagnosis of Chronic HF and currently stable with optimal medical therapy * Chronic Heart failure with ejection fraction \> 30 % * Patient able to safely perform lower limb exercise will be check by six- minute walk test (6 MWT) Exclusion Criteria: * Those Heart failure patient whose are in acute phase or planed for any immediate medical intervention * Already participating in cardiac rehabilitation * New York Heart Association (NYHA) Classification of HF class IV HF symptoms * Co-existent other disease such as asthma/ COPD/interstitial lung disease. * Symptomatic Second degree or third degree heart block. * ECG with uncontrolled ventricular arrhythmia * Limited Exercise ability due to neurologic or orthopedic impairments of the legs (will cross-check with 6 MWT)
Contact & Investigator
Muhammad Iqbal Tariq, PhD*
PRINCIPAL INVESTIGATOR
Riphah International University
Frequently Asked Questions
Who can join the NCT06032780 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Heart Failure. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06032780 currently recruiting?
Yes, NCT06032780 is actively recruiting participants. Contact the research team at iqbal.tariq@riphah.edu.pk for enrollment information.
Where is the NCT06032780 trial being conducted?
This trial is being conducted at Rawalpindi, Pakistan, Rawalpindi, Pakistan.
Who is sponsoring the NCT06032780 clinical trial?
NCT06032780 is sponsored by Riphah International University. The principal investigator is Muhammad Iqbal Tariq, PhD* at Riphah International University. The trial plans to enroll 84 participants.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.